Connie Newman
#94,053
Most Influential Person Now
American endocrinologist and physician-scientist
Connie Newman's AcademicInfluence.com Rankings
Connie Newmanphilosophy Degrees
Philosophy
#12266
World Rank
#17008
Historical Rank
#2386
USA Rank
Logic
#9114
World Rank
#11495
Historical Rank
#1575
USA Rank
Download Badge
Philosophy
Connie Newman's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biochemistry University of California, San Francisco
Why Is Connie Newman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Connie Baum Newman is an American endocrinologist and physician-scientist specializing in hypercholesterolemia and lipid disorders, women's rights, and access to reproductive healthcare. She is an adjunct professor of medicine at the New York University Grossman School of Medicine. Newman was president of the American Medical Women's Association from 2019 to 2020.
Connie Newman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association (2019) (346)
- Acetaldehyde adducts with hemoglobin. (1981) (325)
- Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy (2012) (293)
- Octreotide treatment of acromegaly. A randomized, multicenter study. (1992) (270)
- Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. (1995) (258)
- Octreotide as primary therapy for acromegaly. (1998) (253)
- Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. (2003) (185)
- Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients. (2006) (157)
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry (2016) (156)
- Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. (1992) (121)
- Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study [published erratum appears in J Clin Endocrinol Metab 1995 Nov;80(11):3238] (1995) (111)
- Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland. (1990) (106)
- Gender-Based Differences in Burnout: Issues Faced by Women Physicians (2019) (103)
- The nocebo effect in the context of statin intolerance. (2016) (99)
- Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). (2009) (85)
- Statin intolerance: reconciling clinical trials and clinical experience. (2015) (59)
- Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care (2016) (54)
- Medical therapy for acromegaly. (1999) (53)
- US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. (2016) (50)
- Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. (2020) (44)
- Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS) (2007) (43)
- The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS) (2008) (41)
- Erratum: Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study (Journal of Clinical Endocrinoloy and Metabolism (1995) 80 (2768-2775)) (1995) (39)
- Statin tolerability: In defence of placebo-controlled trials (2015) (38)
- Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS) (2009) (33)
- EFFECT OF CV 205‐502 IN HYPERPROLACTINAEMIC PATIENTS INTOLERANT OF BROMOCRIPTINE (1989) (32)
- Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis. (2020) (30)
- Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study. (1994) (29)
- Endocrine function in children with intrasellar and suprasellar neoplasms: before and after therapy. (1981) (29)
- Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group. (1993) (29)
- Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland. (1987) (26)
- Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials (2015) (25)
- Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function. (2011) (24)
- Supression of basal and stress-induced prolactin release and stimulation of luteinizing hormone secretion by α-melanocyte-stimulating hormone☆ (1985) (23)
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
- AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus (2006) (22)
- Reasons behind current gender imbalances in senior global health roles and the practice and policy changes that can catalyze organizational change (2017) (19)
- Weight Loss and Serum Lipids in Overweight and Obese Adults: A Systematic Review and Meta-analysis. (2020) (19)
- Exercise prescription for weight management in obese adults at risk for osteoarthritis: synthesis from a systematic review (2019) (18)
- Estimation of the optimum dose of vitamin D for disease prevention in older people: Rationale, design and baseline characteristics of the BEST-D trial (2015) (16)
- Adult Growth Hormone Deficiency (1998) (12)
- Dopaminergic Regulation of α-Melanocyte-Stimulating Hormone and N-Acetyl-β-Endorphin Secretion in the Fetal Lamb (1987) (11)
- Suppression of basal and stress-induced prolactin release and stimulation of luteinizing hormone secretion by alpha-melanocyte-stimulating hormone. (1985) (11)
- Prolactin response to breast stimulation in lactating women is not mediated by endogenous opioids. (1984) (11)
- Management of Dyslipidemia for Cardiovascular Disease Risk Reduction (2016) (9)
- Adrenocorticotropin immunoactivity in monkey hypophyseal portal blood. (1984) (8)
- Mortality in COVID-19: Further Evidence for a Sex-Based Difference in the OpenSAFELY Study. (2020) (7)
- Inequity and Women Physicians: Time to Change Millennia of Societal Beliefs. (2020) (6)
- Statin‐Related Myopathy and Rhabdomyolysis (2018) (6)
- Abstract 12169: LDL-C Levels and Treatment Patterns Among Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry (2015) (5)
- Mo-W14:4 Apolipoproteins as predictors of cardiovascular risk in the collaborative atorvastatin diabetes study (Cards) (2006) (5)
- Effects of endocrine disorders on lipids and lipoproteins. (2022) (4)
- Assessment of Burnout: A Pilot Study of International Women Physicians. (2020) (3)
- Comment on the article by Moriarty et al. (2016) (2)
- Hemoglobin adducts with acetaldehyde (1980) (2)
- Comparative safety of atorvastatin 80mg vs 10mg derived from analysis of 49 completed trials (2005) (2)
- The Pituitary Gland in Primate Mammary Development: Evidence That Prolactin Is Not Essential (1986) (2)
- Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS) (2008) (2)
- Octreotide Treatment of Acromegaly (2020) (1)
- Safety of Statins and Nonstatins for Treatment of Dyslipidemia. (2022) (1)
- Response to Letter to the Editor: "Lipid Management in Patients With Endocrine Disorders: An Endocrine Society Clinical Practice Guideline". (2021) (1)
- Management of Dyslipidemia and Atherosclerotic Cardiovascular Risk in Prediabetes. (2022) (1)
- Exploring Obesity as a Gendered Contagion: Impact on Lifestyle Interventions to Improve Cardiovascular Health (2021) (1)
- COVID-19 and Pregnancy: A public health, evidence-based approach (2021) (0)
- Update on Lipids and Lipoproteins. (2022) (0)
- Dopaminergic regulation of alpha-melanocyte-stimulating hormone and N-acetyl-beta-endorphin secretion in the fetal lamb. (1987) (0)
- Metabolic disorders: Sex and gender evidence in dyslipidemia, diabetes, and obesity (2021) (0)
- Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*† (2015) (0)
- 1P-0295 Analysis of the musculoskeletal safety of atorvastatin in a broad spectrum of patients with dyslipidemia (2003) (0)
- Targeting PCSK9 with Antibodies and Gene Silencing to Reduce LDL-cholesterol. (2022) (0)
- Management of Hyperlipidemia in the Statin-Intolerant Patient (2015) (0)
- Lack of effect of higher dose vitamin D supplements on systolic blood pressure and arterial stiffness measure in older people after 12 months of treatment. Results of BEST-D trial (2015) (0)
- Lipids: Update on Diagnosis and Management of Dyslipidemia (2022) (0)
- Mind the Gap: Exploring Nutritional Health Compared With Weight Management Interests of Individuals with Osteoarthritis (2022) (0)
- Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement. (2023) (0)
- Sex and Gender Health Educational Tenets: A Report from the 2020 Sex and Gender Health Education Summit (2022) (0)
- List of Contributors (2021) (0)
- Evidence Review for Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement. (2023) (0)
- Introduction (2021) (0)
- Application of sex and gender health: A practical framework (2021) (0)
- W16-P-058 Comparative safety of atorvastatin 80MG vs I0 MG derived from analysis of 49 completed trials (2005) (0)
This paper list is powered by the following services:
Other Resources About Connie Newman
What Schools Are Affiliated With Connie Newman?
Connie Newman is affiliated with the following schools:
